Purdue Pharma L.P. v. Commonwealth of KentuckyPurdue Pharma L.P. v. Commonwealth of Kentucky
The Commonwealth of Kentucky (“Kentucky” or “the Commonwealth“), through its Attоrney General, and Pike County, Kentucky (“the County“) (collectively, “Plaintiffs“) commenced this action in Kentucky state court against Purdue Pharma, L.P.; Purdue Pharma, Inc.; Purdue Frederick Company, Inc.; Purdue Pharmaceuticals, L.P.; and P.F. Laboratories, Inc. (collectively, “Purdue“), alleging that Purdue violated Kentucky law by misleading health care providers, consumers, and government officials regarding the risks of addiction associated with the prescription drug OxyContin, which Purdue manufactures, markets and sells. Purdue removed the action to federal court, arguing inter alia that Plaintiffs’ claims constituted a putative “class action” removable under the Class Action Fairness Act of 2005 (“CAFA“), Pub.L. No. 109-2, 119 Stat. 4 (codified in scattered sections of
I.
Plaintiffs’ state court complaint contained the following allegations. Purdue manufactures and sells OxyContin, an opioid analgesic drug used to manage pain. See Am. Compl., at ¶¶ 23-24. From 1995 to 2001, Purdue promoted OxyContin to health care providers as “less addictive, less subject to abuse and diversion, and less likely to cause tolerance and withdrawal than other pain medications,” despite knowing that such assertions were false or misleading. Id. ¶ 42. According to Plaintiffs, Purdue‘s actions prevented Kentuckians from accurately assessing the appropriate uses and risks of OxyContin, and caused physicians to overprescribe OxyContin, which resulted in widespread addiction and other adverse consequences, including death and “the commission of criminal acts to obtain OxyContin.” Id. ¶¶ 2, 68, 84. Kentucky, which covers health care costs for indigent and otherwise eligible residents under its Medicaid and Pharmaceutical Assistance Programs, bore significant аdditional costs as a result of Purdue‘s actions. Similarly, Pike County spent millions of dollars investigating, apprehending, prosecuting, and incarcerating persons who, “due to the fraudulently concealed addictive nature of OxyContin, have resorted to criminal means to continue their addiction.” Id. ¶¶ 4, 8-9.
The complaint indicated that the action was brought pursuant to the Kentucky Attorney General‘s authority under state statutory and common law, “including [his] parens patriae authority,” to recover, inter alia, “all the costs the Commonwealth ... incurred in paying excessive and unnecessary prescription costs“; “all the costs expended for health care services and programs assoсiated with the diagnosis and treatment of adverse health consequences of OxyContin use“; and “all the costs consumers have incurred in excessive and unnecessary prescription costs related to OxyContin.” Id. ¶¶ 5-6. Specifically, Plaintiffs asserted the following claims under state law: (1) violation of the Kentucky Medicaid Fraud Statute,
Purdue removed the action to federal court, asserting that Plaintiffs’ claims (1) raised federal questions under
II.
As a general rule, “[a]n order remanding a case ... is not reviewable on appeal or otherwise.”
III.
Purdue seeks leave to appeal the District Court‘s remand order, insisting this case presents an “important” and “unsettled” question under CAFA—namely, whether parens patriae lawsuits brought by state attorneys general qualify as “class actions” under CAFA. See Defs.’ Pet. For Leave to Appeal, at 1-2.3 We concede the importance of the question, but in light of recent decisions by our Sister Circuits, we determine that the answer is straightforward. Indeed, every Circuit to consider this precise issue—including the Fourth, the Seventh, the Ninth and, most recently, the Fifth—has reached the same conclusion we reach today: parens patriae suits are not removable as “class actions” under CAFA. See West Virginia ex rel. McGraw v. CVS Pharmacy, Inc., 646 F.3d 169, 172 (4th Cir.2011) (“Because this [parens patriae] action was brought by the State under state statutes that are not ‘similar’
A.
We begin with the apodictic observation that “federal courts are courts of limited jurisdiction” and, as such, “lack the power to disregard such limits as have been imposed by the Constitution or Congress.” Durant, Nichols, Houston, Hodgson, & Cortese-Costa, P.C. v. Dupont, 565 F.3d 56, 62 (2d Cir.2009) (quotation omitted). Congress has granted district courts original jurisdiction over cases in which there is a federal question, see
In tandem with this limited grant of jurisdiction, the “federal removal statute allows a defendant to remove an action to the Unitеd States District Court in ‘any civil action brought in a State court of which the district courts of the United States have original jurisdiction.‘” Bounds v. Pine Belt Mental Health Care Res., 593 F.3d 209, 215 (2d Cir.2010) (quoting
CAFA “expanded the jurisdiction of the federal courts to allow class actions originally filed in state courts that conform to particular requirements to be removed to federal district courts.” Greenwich Fin. Servs. Distressed Mortg. Fund 3 LLC v. Countrywide Fin. Corp., 603 F.3d 23, 26 (2d Cir.2010). In genеral, CAFA amended the diversity statute to confer federal jurisdiction over certain class actions where: (1) the proposed class contains at least 100 members (the “numerosity” requirement); (2) minimal diversity exists between the parties, (i.e., where “any member of a class of plaintiffs is a citizen of a State different from any defendant“); and (3) the aggregate amount in controversy exceeds $5,000,000.
CAFA‘s reach, however, is limited in the first instance to actions that qualify as either a “class action” or a “mass action.” See
B.
Purdue removed this action as a purported “class action” under CAFA.5 The threshold inquiry, therefore, is whether this action meets CAFA‘s definition of a “class action.” We begin our analysis, as we must, with the plain language of the statute. See Conn. Nat‘l Bank v. Germain, 503 U.S. 249, 253-54, 112 S.Ct. 1146, 117 L.Ed.2d 391 (1992) (“[I]n interpreting a statute, a court should always turn first to [this] one, cardinal canon before all others.... When the words of a statute are unambiguous, then, this first canon is also the last: judicial inquiry is complete.“) (quotation omitted). As noted above, CAFA defines a “class action” as “any civil action filed under
1.
Here, Plaintiffs claim to bring this suit in both proprietary and parens patriae capacities, seeking: (1) restitution and reimbursement for damages suffered directly by the Commonwealth and the County as a result of, inter alia, unnecessary prescriptions costs and Medicaid claims paid out of the state treasury; (2) civil penalties, fines and attorneys’ fees; and (3) equitable and injunctive relief based on “quasi-sovereign interests” in protecting the health and safety of citizens. Specifically, Plaintiffs’ state-court complaint alleged violations of the following state statutes: (1)
Plaintiffs seek to enforce these various claims under two different statutory provisions: (1)
None of these statutes, however, authorizes suit “as a class action,” nor does either bear any resemblance to
2.
Against this straightforward application of CAFA‘s statutory prescriptions, Purdue puts forward several arguments in favor of removal—none of which is convincing.
In Purdue‘s estimation, there is more to this case than meets the eye. We are therefore urged to look past the pleadings, the named parties, and the stated causes of action to deduce the true nature of this proceeding. By “piercing the pleadings,” and dissecting the complaint claim by claim, Purdue hopes we will conclude that, for certain claims, the “real parties in interest” are not the Commonwealth or the County, but individual consumers for whom the Attorney General is acting, in effect, as a disguised class representative. Purdue buttresses this argument with choice phrases plucked from the complaint—most notably, a single sentence from the “Prayer for Relief,” which seeks “restitution and reimbursement for all prescription costs consumers have incurred in excessive and unnecessary prescription costs related to OxyContin.” Prayer for Relief, at ¶ H (emphasis added). Building on this claim-by-claim approach, Purdue presses us to conclude that CAFA‘s requirements for minimal diversity, numerosity, and amount in controversy are satisfied.8
As authority for its claim-by-claim approach, Purdue cites Louisiana ex rel. Caldwell v. Allstate Ins. Co., 536 F.3d 418 (5th Cir.2008). In Caldwell, the Fifth Circuit declined to remand an attorney general‘s antitrust action in which the State sought to collect, under its parens patriae authority, treble damages on behalf of certain citizen-policyholders. Id. at 422-23, 432. Noting that Congress, in passing CAFA, had “emphasized that the term ‘class action’ should be defined broadly to prevent ‘jurisdictional gamesmanship,‘” id. at 424 (quoting S.Rep. No. 109-14, at 35 (2005), 2005 U.S.C.C.A.N. 3), the court analyzed the real parties in interest on a claim-by-claim basis, rather than looking at the lawsuit as a whole. Id. at 425, 429-30. After carefully considering whether the State or its citizens were the “real parties” with respect to each type of relief sought, the Court “conclude[d] that as far as the State‘s request for treble damages is concerned, the policyholders are the real parties in interest,” and the action was therefore properly removed as a “mass action” under CAFA. Id. at 429-30. Relying heavily on Caldwell, and arguing that this action, too, is merely masquerading as a parens patriae action to avoid CAFA‘s reach, Purdue invites us to adopt the claim-by-claim approach to unmask the “class action” lurking underneath.
We decline that invitation.
First, Caldwell‘s holding addresses only CAFA‘s ”mass action” provisions, not the “сlass action” provisions we encounter here. See Caldwell, 536 F.3d at 430 (“Since we have concluded that this case was properly removed under CAFA‘s ‘mass action’ provision, we need not address whether this lawsuit could, following further proceedings on remand, properly proceed as a class action under CAFA.“); see also In re Vioxx Prods. Liab. Litig., 843 F.Supp.2d 654, 660 (E.D.La.2012) (“[T]he Fifth Circuit‘s precise holding in Caldwell is limited to the CAFA definition of mass actions, not class actions. The court expressly declined to decide whether the parens patriae lawsuit could also proceed as a class action on remand....“). Purdue removed this action as a “class action,” and has never contended that this action qualifies аs a “mass action.”9
Second, we note that the “claim-by-claim” approach has been roundly criticized, and the “whole-complaint” approach has emerged as the majority rule. See, e.g., AU Optronics Corp. v. South Carolina, 699 F.3d 385, 390, 393-94 (4th Cir.2012) (addressing application of CAFA‘s “mass action” provisions by “adopting the whole-case approach and rejecting the claim-by-claim approach“); Nevada v. Bank of Am. Corp., 672 F.3d 661, 669-70 (9th Cir.2012) (employing “the approach of looking at the case as a whole to determine the real party in interest, rather than the claim-by-claim approach adopted in Caldwell“); Madigan, 665 F.3d at 773-74 (rejecting Caldwell‘s claim-by-claim approach, noting “just because CAFA was meant to еxpand federal courts’ jurisdiction over class actions, it does not follow that federal courts are required to deviate from the traditional ‘whole complaint’ analysis when evaluating whether a State is the real party in interest in a parens patriae case“) (internal quotation omitted); see also Ohio v. GMAC Mortg., LLC, 760 F.Supp.2d 741, 745 (N.D.Ohio 2011) (“[A] majority of jurisdictions ... have looked at a state‘s complaint as a whole to determine whether the state is the real-party-in-interest.“).
We have not yet passed on whether the real-party-in-interest inquiry should be made on the basis of the whole complaint or claim by claim, and district courts within this Circuit—considering the issue both before and after CAFA—appear to be split. Some have applied a claim-by-claim approach. See, e.g., Connecticut v. Levi Strauss & Co., 471 F.Supp. 363, 370-71 (D.Conn.1979) (analyzing separately each type of relief sought in the State‘s complaint to determine whether the State was the real party in interest for diversity purposes); see also Connecticut v. Chubb Group of Ins. Cos., No. 3:11-cv-997, 2012 WL 1110488, at *3 (D.Conn. Mar. 31, 2012) (following Levi Strauss, 471 F.Supp. at 370-71); Butler v. Cadbury Beverages, Inc., No. 3:97-cv-2241, 1998 WL 422863, at *2 (D.Conn. July 1, 1998) (same). Others have looked to the complaint as a whole. See New York ex rel. Abrams v. General Motors Corp., 547 F.Supp. 703, 704-07 (S.D.N.Y.1982) (looking to “the primary purpose of the action” to determine the real party in interest); MyInfoGuard, LLC v. Sorrell, Nos. 2:12-cv-074, 2:12-cv-102, 2012 WL 5469913, at *4-5 (D.Vt. Nov. 9, 2012) (rejecting Caldwell and stating “[t]his Court adopts the wholesale approach“); Connecticut v. Moody‘s Corp., No. 3:10-cv-546, 2011 WL 63905, at *3 (D.Conn. Jan. 5, 2011) (considering “the State‘s stake in the litigation as a whole“); New York ex rel. Cuomo v. Charles Schwab & Co., Inc., No. 09-cv-7709, 2010 WL 286629, at *4-6 (S.D.N.Y. Jan. 19, 2010) (same).
But we need not decide that issue today. Whatever the comparative merits of a “claim-by-clаim” versus “whole-complaint”
One final point. Our decision today merely concerns CAFA‘s jurisdictional reach over this action, not whether the action is otherwise sufficient as a matter of state law. Whether Plaintiffs may proceed and ultimately recover on their claims presents complex questions of Kentucky law, which we only see through Erie‘s glass darkly, and upon which we express no opinion.
IV.
In sum, the District Court correctly determined that Plaintiffs’ action is not a “class action” as defined in CAFA, and therefore the case was properly remanded.
Notes
To the extent we understand this serpentine line of reasoning, we disagree. Under CAFA‘s plain language, a “class action” is defined as a civil action ”filed under” a state-law equivalent to